TriSalus Life Sciences (TLSI) Other Accumulated Expenses (2022 - 2026)

TriSalus Life Sciences has reported Other Accumulated Expenses for 5 years, with the latest figure at $269000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses fell 36.85% year-over-year to $269000.0; the trailing twelve-month figure through Mar 2026 stood at $269000.0 (down 36.85% YoY), and the FY2025 full-year result was $234000.0, down 38.9% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $269000.0, up from $234000.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $427000.0 in Q3 2023, with the low at $142000.0 in Q4 2022.
• Historically, Other Accumulated Expenses has averaged $299583.3 across 5 years, with a median of $280000.0 in 2024.
• Annual changes were most pronounced in 2023 — Other Accumulated Expenses soared 173.94% — and 2025, when it plunged 38.9%.
• TriSalus Life Sciences' Other Accumulated Expenses stood at $142000.0 in 2022, then soared by 173.94% to $389000.0 in 2023, then dropped by 1.54% to $383000.0 in 2024, then tumbled by 38.9% to $234000.0 in 2025, then increased by 14.96% to $269000.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $269000.0 (Q1 2026), $234000.0 (Q4 2025), and $224000.0 (Q3 2025), per Business Quant data.